Vijay N. Joish, Ph.D. - Publications

2003 University of Arizona, Tucson, AZ 
Pharmacy, Health Care Management, Public Health

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, Pirozzi G, Sutherland ER, Evans RR, Joish VN, Eckert L, Graham NM, Stahl N, Yancopoulos GD, Louis-Tisserand M, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet (London, England). PMID 27130691 DOI: 10.1016/S0140-6736(16)30307-5  0.56
2014 Burudpakdee C, Shah A, Joish VN, Divers C, Yaldo A. Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension. American Health & Drug Benefits. 7: 479-87. PMID 25610527  0.56
2014 Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Cummings AK, Joish VN. Implications of early treatment among Medicaid patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 214-24. PMID 23643457 DOI: 10.1016/j.jalz.2013.01.015  0.56
2013 Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Cummings AK, Joish VN. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population. Applied Health Economics and Health Policy. 11: 407-13. PMID 23700254 DOI: 10.1007/s40258-013-0038-9  0.56
2013 Joish VN, Spilsbury-Cantalupo M, Operschall E, Luong B, Boklage S. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective. Applied Health Economics and Health Policy. 11: 299-304. PMID 23580074 DOI: 10.1007/s40258-013-0027-z  0.56
2012 Joish VN, Lin G, Lynen R. Healthcare-related characteristics of low vs normal folate levels among women of child-bearing age. Journal of Medical Economics. 15: 807-16. PMID 22458715 DOI: 10.3111/13696998.2012.680997  0.56
2012 Said Q, Martin BC, Joish VN, Kreilick C, Mathai SC. The cost to managed care of managing pulmonary hypertension. Journal of Medical Economics. 15: 500-8. PMID 22313330 DOI: 10.3111/13696998.2012.665109  0.56
2012 Sansgiry SS, Joish VN, Boklage S, Goyal RK, Chopra P, Sethi S. Economic burden of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Journal of Medical Economics. 15: 219-24. PMID 22084956 DOI: 10.3111/13696998.2011.638954  0.56
2011 Joish VN, Boklage S, Lynen R, Schmidt A, Lin J. Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources. Journal of Medical Economics. 14: 681-9. PMID 21892859 DOI: 10.3111/13696998.2011.617803  0.56
2011 Mark TL, Joish VN, Hay JW, Sheehan DV, Johnston SS, Cao Z. Antidepressant use in geriatric populations: the burden of side effects and interactions and their impact on adherence and costs. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 211-21. PMID 21425504 DOI: 10.1097/JGP.0b013e3181f1803d  0.56
2010 Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL. Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings among anxiety and depression sufferers: results of a national survey. Primary Care Companion to the Journal of Clinical Psychiatry. 12. PMID 20694118 DOI: 10.4088/PCC.09m00824gry  0.56
2010 Asche CV, Joish VN, Camacho F, Drake CL. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder. Current Medical Research and Opinion. 26: 1843-53. PMID 20515321 DOI: 10.1185/03007995.2010.488037  0.56
2010 Zammit GK, Joish VN, Kong MC, Balkrishnan R, Lerner D, Rosekind M. Impact of nighttime awakenings on worker productivity and performance. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 52: 513-8. PMID 20431417 DOI: 10.1097/JOM.0b013e3181d8db23  0.56
2010 Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL. Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings. Population Health Management. 13: 15-20. PMID 20158319 DOI: 10.1089/pop.2009.0028  0.56
2010 Birnbaum HG, Kessler RC, Kelley D, Ben-Hamadi R, Joish VN, Greenberg PE. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depression and Anxiety. 27: 78-89. PMID 19569060 DOI: 10.1002/da.20580  0.56
2009 Pollack M, Seal B, Joish VN, Cziraky MJ. Insomnia-related comorbidities and economic costs among a commercially insured population in the United States. Current Medical Research and Opinion. 25: 1901-11. PMID 19530979 DOI: 10.1185/03007990903035505  0.56
2009 Lasch K, Joish VN, Zhu Y, Rosa K, Qiu C, Crawford B. Validation of the sleep impact scale in patients with major depressive disorder and insomnia. Current Medical Research and Opinion. 25: 1699-710. PMID 19505198 DOI: 10.1185/03007990902973201  0.56
2009 Balkrishnan R, Pollack M, Joish VN, Asche CV, Pawaskar MD, Cziraky MJ. An economic evaluation of therapeutic alteration in the management of insomnia. Current Medical Research and Opinion. 25: 663-9. PMID 19196222 DOI: 10.1185/03007990802714713  0.56
2008 Pawaskar MD, Joish VN, Camacho FT, Rasu RS, Balkrishnan R. The influence of co-morbidities on prescribing pharmacotherapy for insomnia: evidence from US national outpatient data 1995-2004. Journal of Medical Economics. 11: 41-56. PMID 19450109 DOI: 10.3111/13696990701817491  0.56
2008 Balkrishnan R, Joish VN, Yang T, Jayawant SS, Mullins CD. The economic burden associated with SSRI treatment failure in a managed care population. Journal of Medical Economics. 11: 601-10. PMID 19450070 DOI: 10.3111/13696990802522339  0.56
2008 Erman M, Guiraud A, Joish VN, Lerner D. Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial. Sleep. 31: 1371-8. PMID 18853934  0.56
2007 Balkrishnan R, Joish VN, Bhosle MJ, Rasu RS, Nahata MC. Prior authorization of newer insomnia medications in managed care: is it cost saving? Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 3: 393-8. PMID 17694729  0.56
2007 Brixner DI, Joish VN, Odera GM, Avey SG, Hanson DM, Cannon HE. Effects of benefit design change across 5 disease states. The American Journal of Managed Care. 13: 370-6. PMID 17567238  0.56
2007 Ho MJ, Joish VN, White GL, Alder SC, Oderda GM. Evaluating the relationship between daily self-monitoring of blood glucose and healthcare costs Journal of Medical Economics. 10: 17-26.  0.56
2006 LaFleur J, Thompson CJ, Joish VN, Charland SL, Oderda GM, Brixner DI. Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin. The Annals of Pharmacotherapy. 40: 1274-9. PMID 16849622 DOI: 10.1345/aph.1G646  0.56
2006 Joish VN, Brady E, Stockdale W, Brixner DI, Dirani R. Evaluating Diagnosis and Treatment Patterns of COPD in Primary Care. Treatments in Respiratory Medicine. 5: 283-93. PMID 16808547 DOI: 10.2165/00151829-200605040-00006  0.56
2005 Joish VN, Malone DC, Wendel C, Draugalis JR, Mohler MJ. Development and validation of a diabetes mellitus severity index: a risk-adjustment tool for predicting health care resource use and costs. Pharmacotherapy. 25: 676-84. PMID 15899729 DOI: 10.1592/phco.25.5.676.63594  0.56
2005 Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Current Medical Research and Opinion. 21: 535-44. PMID 15899102 DOI: 10.1185/030079905X38240  0.56
2005 Joish VN, Oderda GM. Cost-utility analysis and quality adjusted life years. Journal of Pain & Palliative Care Pharmacotherapy. 19: 57-61. PMID 15814516 DOI: 10.1300/J354v19n01_10  0.56
2005 White R, Ho MJ, Joish VN, Biskupiak J. Triptan use in the real world P and T. 30: 199-201.  0.56
2005 Ho MJ, Joish VN, Biskupiak JE. The role of pharmacoeconomics in formulary management: Triptan case study for migraine P and T. 30: 36-46.  0.56
2004 Joish VN, Brixner DI. Back pain and productivity: measuring worker productivity from an employer's perspective. Journal of Pain & Palliative Care Pharmacotherapy. 18: 79-85. PMID 15257978  0.56
2004 Joish VN, Malone DC, Wendel C, Mohler MJ. Profiling quality of diabetes care in a Veterans Affairs Healthcare System. American Journal of Medical Quality : the Official Journal of the American College of Medical Quality. 19: 112-20. PMID 15212316  0.56
2004 Lempert P, Joish VN, Malone DC, Miller JM. A cost-benefit analysis of visionscreening methods for preschoolers and school-age children (multiple letters) Journal of Aapos. 8: 74-75. PMID 15008161 DOI: 10.1016/j.jaapos.2003.10.010  0.56
2004 Ho MJ, Joish VN, LaFleur J, Christensen RL, Brixner DI. Pharmacoeconomic analysis of oral triptans Formulary. 39: 356-357.  0.56
2003 Joish VN, Sahai A. Evaluating the role of confounding in pharmacoeconomic studies. Managed Care Interface. 16: 30-3, 35. PMID 14750461  0.56
2003 Epple C, Wright AL, Joish VN, Bauer M. The role of active family nutritional support in Navajos' type 2 diabetes metabolic control. Diabetes Care. 26: 2829-34. PMID 14514587 DOI: 10.2337/diacare.26.10.2829  0.56
2003 Joish VN, Malone DC, Miller JM. A cost-benefit analysis of vision screening methods for preschoolers and school-age children. Journal of Aapos : the Official Publication of the American Association For Pediatric Ophthalmology and Strabismus / American Association For Pediatric Ophthalmology and Strabismus. 7: 283-90. PMID 12917617 DOI: 10.1016/mpa.2003.S1091853103001162  0.56
2002 Joish VN, Armstrong EP. Newer drugs and overall costs of treating onychomycosis. Revista Iberoamericana De MicologíA. 19: 130-2. PMID 12825989  0.56
2002 Shaw JW, Joish VN, Coons SJ. Onychomycosis: health-related quality of life considerations. Pharmacoeconomics. 20: 23-36. PMID 11817990  0.56
2001 Joish VN, Armstrong EP. Which Antifungal Agent for Onychomycosis? A Pharmacoeconomic Analysis Pharmacoeconomics. 19: 983-1002. PMID 11735669  0.56
2001 Joish VN. Evaluating the role of bias in pharmacoeconomic studies Managed Care Interface. 14: 57-60. PMID 11517839  0.56
2001 Joish VN, Cady PS. Effect of sumatriptan on health care resource use among patients with migraine. Managed Care Interface. 14: 68-72. PMID 11214537  0.56
2001 Joish VN, Limcangco MRMT, Armstrong EP. Cost-benefit analysis of a pharmacist-advocated pneumococcal vaccination program Formulary. 36: 147-156.  0.56
2000 Joish VN, Cady PS, Shaw JW. Health care utilization by migraine patients: a 1998 Medicaid population study. Clinical Therapeutics. 22: 1346-56. PMID 11117659 DOI: 10.1016/S0149-2918(00)83031-3  0.56
2000 Joish VN, Armstrong EP. Use of decision analysis in modeling the cost-effectiveness of oral vs SC sumatriptan Formulary. 35: 532-539.  0.56
Show low-probability matches.